Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
Coll freshman Avg
|
New words:
advisor, Biomedical, complementary, covenant, cyclophosphamide, Dan, deceit, denying, description, dispute, Dr, ease, enrichment, ERC, faith, fludarabine, grow, Kaufman, lawsuit, multifunctional, multinational, oncology, rapidly, refundable, restitution, routinely, safer, satisfactory, Shoreline, shortage, slightly, somatic, Southern, tumor, Ukrainian, unjust, wage, Whitehead
Removed:
eighteen, settlement
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view